理解机器学习在预测骨关节炎进展中的作用
该系统综述依据PRISMA指南检索MEDLINE和Embase(2024年5月5日),纳入39项利用机器学习预测骨关节炎进展的研究,发现多数研究使用公开数据集且以结构改变为结局,评估指标缺乏标准化且外部验证有限,结论认为机器学习模型预测骨关节炎进展可行但临床适用性受限。
要点
- 纳入39项研究,85%发表于2020至2024年,82%使用公开数据集,主要为骨关节炎倡议(Osteoarthritis Initiative)数据集。
- 骨关节炎进展定义差异大,多数研究关注结构改变(59%),44%使用深度学习,5%使用自动化机器学习。
- 评估指标缺乏标准化且外部验证有限,54%的研究探索了可解释性,主要使用SHapley Additive exPlanations。
核心结论
- 该系统综述表明机器学习模型预测骨关节炎进展具有可行性,但也揭示了目前限制其临床适用性的关键局限性。
- 未来优先方向应包括多样化数据来源、标准化结局指标、实施严格验证以及整合更复杂的算法。
- 从预测建模向可操作的临床工具转变,有潜力改变骨科实践中的患者照护和疾病管理。
研究设计与样本
- 依据PRISMA指南开展的系统综述,检索MEDLINE和Embase(2024年5月5日),独立筛选标题和摘要后对符合纳入标准的研究进行全文审查。
- 从1160项初筛研究中最终纳入39项利用机器学习预测骨关节炎进展的研究。
- 提取并综合分析的关键信息包括数据类型(如临床、影像或生化)、骨关节炎进展定义、机器学习算法、验证方法和结局指标。
主要发现
- 39项研究中85%发表于2020年至2024年,82%使用公开数据集,主要为骨关节炎倡议(Osteoarthritis Initiative)数据集。
- 机器学习方法以监督学习为主,骨关节炎进展定义存在显著差异:多数研究关注结构改变(59%),较少研究涉及疼痛进展或两者兼有。
- 44%的研究使用深度学习,5%使用自动化机器学习;评估指标缺乏标准化,外部验证有限。
- 54%的研究探索了可解释性,主要使用SHapley Additive exPlanations。
局限性
- 骨关节炎进展的定义存在显著差异。
- 评估指标缺乏标准化。
- 外部验证有限。
- 目前存在限制机器学习模型临床适用性的关键局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Machine learning (ML), a branch of artificial intelligence that uses algorithms to learn from data and make predictions, offers a pathway towards more personalized and tailored surgical treatments. This approach is particularly relevant to prevalent joint diseases such as osteoarthritis (OA). In contrast to end-stage disease, where joint arthroplasty provides excellent results, early stages of OA currently lack effective therapies to halt or reverse progression. Accurate prediction of OA progression is crucial if timely interventions are to be developed, to enhance patient care and optimize the design of clinical trials. METHODS: A systematic review was conducted in accordance with PRISMA guidelines. We searched MEDLINE and Embase on 5 May 2024 for studies utilizing ML to predict OA progression. Titles and abstracts were independently screened, followed by full-text reviews for studies that met the eligibility criteria. Key information was extracted and synthesized for analysis, including types of data (such as clinical, radiological, or biochemical), definitions of OA progression, ML algorithms, validation methods, and outcome measures. RESULTS: Out of 1,160 studies initially identified, 39 were included. Most studies (85%) were published between 2020 and 2024, with 82% using publicly available datasets, primarily the Osteoarthritis Initiative. ML methods were predominantly supervised, with significant variability in the definitions of OA progression: most studies focused on structural changes (59%), while fewer addressed pain progression or both. Deep learning was used in 44% of studies, while automated ML was used in 5%. There was a lack of standardization in evaluation metrics and limited external validation. Interpretability was explored in 54% of studies, primarily using SHapley Additive exPlanations. CONCLUSION: Our systematic review demonstrates the feasibility of ML models in predicting OA progression, but also uncovers critical limitations that currently restrict their clinical applicability. Future priorities should include diversifying data sources, standardizing outcome measures, enforcing rigorous validation, and integrating more sophisticated algorithms. This paradigm shift from predictive modelling to actionable clinical tools has the potential to transform patient care and disease management in orthopaedic practice.
引用
- Castagno S, Gompels B, Strangmark E, et al. Understanding the role of machine learning in predicting progression of osteoarthritis. Bone Joint J. 2024. PMID: 39481441. doi:10.1302/0301-620X.106B11.BJJ-2024-0453.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。